Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Biostar Pharmaceuticals, Inc. Regains Compliance with NASDAQ's Minimum Bid Price Requirement

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2012 | 02:16am CEST

Biostar Pharmaceuticals, Inc. Regains Compliance with NASDAQ's Minimum Bid Price Requirement

XIANYANG, China, April 20, 2012/PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in Chinafor a variety of diseases and conditions, today announced that it has received written notification from the Nasdaq Listing Qualifications department that it has regained compliance with the minimum bid price requirement of $1.00per share for continued listing of its common stock on The NASDAQ Global Market set forth in Nasdaq Listing Rule 5450(a)(1), as its common shares achieved a closing bid price of $1.00or more for 10 consecutive business days prior to the compliance deadline of April 23, 2012and this matter is now closed.

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company's most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. For more information please visit: http://www.biostarpharmaceuticals.com

Safe Harbor relating to the Forward-Looking Statements

Certain statements in this release concerning our future growth prospects are forward-looking statements, within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The company uses words and phrases such as "guidance," "forecasted," "projects," "is expected," "remain confident," "will" and similar expressions to identify forward-looking statements in this press release, including forward-looking statements. Undue reliance should not be placed on forward-looking information. Forward-looking information is based on current expectations, estimates and projections that involve a number of risks, which could cause actual results to vary and in some instances to differ materially from those anticipated by Biostar and described in the forward-looking information contained in this news release. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the Company's ability to maintain its ongoing compliance with the Nasdaq continued listing requirements, success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to sustain our previous levels of profitability including on account of our ability to manage growth, intense competition, wage increases in China, its ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, its ability to successfully complete and integrate potential acquisitions, withdrawal of governmental fiscal incentives, political instability and regional conflicts and legal restrictions on raising capital or acquiring companies outside China. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our most recent Annual Report on Form 10-K for the year ended December 31, 2011, and other subsequent filings. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statements that may be made from time to time by or on our behalf.

For more information contact:




BioStar Pharmaceuticals, Inc. 

The Equity Group, Inc.

Zack Pan, CFO 

Lena Cati

Tel: 405-996-8829 

Tel: 212 836-9611

Email: zpan@aoxing-group.com

Email: lcati@equityny.com

SOURCE Biostar Pharmaceuticals, Inc.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
05:19a JUJIANG CONSTRUCTION : Announced 2016 Interim Results
05:18aDJASIA MARKETS : Asian Markets Drop, Preparing For Bad News From Fed
05:15aDJAsian Shares Fall Ahead of Yellen's Speech
05:14a FPT : Annual Report listed in Top 4
05:14a SOUTHERN GOLD : Notice of Extraordinary General Meeting/Proxy Form
05:09a SINGAPORE EXCHANGE : SGX welcomes AGV Group to Catalist
05:09a FEDERATED FARMERS OF NEW ZEALAND : Get ready to cast your votes
05:08aDJAsian Shares Fall Ahead of Yellen's Speech
05:05aDJLotte Vice President Found Dead Amid Corruption Probe
05:04a CHINA PETROLEUM & CHEMICAL : Sinopec wins bidding for port equipment lubricants of PSA
Latest news
Advertisement
Hot News 
-17.63%AHEAD OF THE TAPE : Dollar Stores Have Surprise Lift -- WSJ
-12.63%SIGNET JEWELERS : Why Are Americans Buying Less Jewelry?
4.44%AMCOR : Flags Growth Ahead after Net Profit Falls 64%
-4.39%MICHAELS : Cuts Outlook After 'Choppy' Environment in First Half
-1.45%MEDTRONIC : Profit Rises, Helped by Lower Expenses
Most Read News
08:52p VOLKSWAGEN : to spend at least $1.2 billion to compensate U.S. dealers - sources
07:30p APPLE : fixes security flaw after UAE dissident's iPhone targeted
08:02p GENERAL MOTORS : GM cleared in second U.S. verdict over crash blamed on ignition switch
06:59p ALLIANZ : Austria's Heta says winding down of assets progressing well
07:26p BARCLAYS : Golf Capsules
Most recommended articles
11:15pDJAsian Shares Fall Ahead of Yellen's Speech
10:52pDJOil Prices Edge Down Ahead of Yellen's Speech
10:33p TOSHIBA : Japan trunk bank sues it for $120 million over accounting scandal
09:03pDJMettler-Toledo to Join S&P 500
08:52p VOLKSWAGEN : German prosecutors review stolen Bosch data for VW dieselgate clues